Rapport Therapeutics, Inc. Common Stock (RAPP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.43B |
| Enterprise Value | 1.38B |
| P/E Ratio | -16.23 |
| PEG Ratio | 0.75 |
| Price/Sales Ratio | 117.97 |
| Price/Book Ratio | 5.54 |
| Enterprise/Revenue | 115.29 |
| Enterprise/EBITDA | -15.57 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -6.86 |
| Operating Margin | -7.68 |
| Return On Assets | -0.3 |
| Return On Equity | -0.29 |
| Revenue | 0 |
| Revenue/Share | 0.42 |
| Gross Profit | 0 |
| EBITDA | -124.08M |
| Net Income | -111.48M |
| Diluted EPS | -2.86 |
| Total Cash | 436.08M |
| Total Cash/Share | 9.19 |
| Total Debt | 10.11M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 15.72 |
| Book Value Per Share | 8.91 |
| 52-Week Change | 237.18 |
| 52-Week High | 50.34 |
| 52-Week Low | 14.11 |
| Moving Average 50 Days | 42.34 |
| Moving Average 200 Days | 33.73 |
| Average Volume | 353,196 |
| Shares Outstanding | 47.83M |
| % Held by Institutions | 111.84 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |